SCHEMBL5125315

SCHEMBL5125315

Cc1ccc(Oc2ccc(N(C[C@H](O)C(N)=O)S(C)(=O)=O)cc2)cc1

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 20/20 0.74
MMP9 P14780 20/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5127877 1.00 MMP2 (0.74) MMP2MMP9
SCHEMBL5131397 0.90 MMP2 (0.74) MMP2MMP9
SCHEMBL5131359 0.90 MMP2 (0.74) MMP2MMP9
SCHEMBL5131893 0.89 MMP2 (0.74) MMP2MMP9
SCHEMBL5126970 0.89 MMP2 (0.74) MMP2MMP9
SCHEMBL5131464 0.89 MMP2 (0.74) MMP2MMP9
SCHEMBL5126230 0.88 MMP2 (0.76) MMP2MMP9
SCHEMBL5127057 0.88 MMP2 (0.75) MMP2MMP9
SCHEMBL5130708 0.88 MMP2 (0.75) MMP2MMP9
SCHEMBL5131374 0.87 MMP2 (0.76) MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080085893-A1 MATRIX METALLOPROTEASE INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085893-A1 MATRIX METALLOPROTEASE INHIBITORS MMP3, MMP7, MMP9 MMP2 5/4885MMP9 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.